No, Xango juice is not recommended as a therapeutic intervention for inflammatory conditions.
While mangosteen-based beverages like Xango juice show modest anti-inflammatory effects in limited research, there is no guideline support for their use, and the clinical benefits are too small and inconsistent to justify recommending them over established anti-inflammatory dietary patterns or medical therapies.
Evidence Assessment
The available evidence consists entirely of small research studies with no guideline recommendations supporting mangosteen juice for inflammatory conditions. The most relevant clinical data comes from two small trials:
Clinical Trial Evidence
The strongest human evidence 1 showed that Xango juice at 18 oz daily reduced C-reactive protein (CRP) compared to placebo in obese subjects over 8 weeks, but this was a pilot study with only 40 completers, and the CRP reduction was not statistically significant within the treatment group—only when comparing change from baseline to placebo. Other inflammatory markers (cytokines, F2 isoprostane) showed no significant differences.
A second trial 2 demonstrated a 46% reduction in CRP and 15% increase in antioxidant capacity after 30 days of mangosteen beverage consumption in healthy adults (n=60). However, this study involved healthy participants without inflammatory disease, limiting its clinical applicability.
Mechanistic Research
Recent laboratory studies 3, 4 confirm that xanthones from mangosteen (particularly α-mangostin, garcinone C, and garcinone D) inhibit inflammatory pathways including NF-κB, COX-2, and pro-inflammatory cytokine production in cell culture models. These are mechanistic findings that do not translate to clinical recommendations.
Guideline-Based Dietary Recommendations
The 2024 guidelines on diet and inflammatory diseases 5 make no mention of mangosteen or specialty fruit juices. Instead, they emphasize:
- Mediterranean-style diet with whole grains, fruits, vegetables, and healthy fats—consistently linked to reduced inflammation and lower risk of chronic inflammatory diseases
- High-fiber diets with prebiotics to promote beneficial gut bacteria
- Omega-3 fatty acids from fish oil for reducing joint pain and stiffness in arthritis
- Avoidance of Western dietary patterns high in processed foods, saturated fats, and refined carbohydrates
For specific inflammatory conditions like rheumatoid arthritis and lupus, guidelines 5 recommend Mediterranean dietary patterns with antioxidant and anti-inflammatory properties, not specialty beverages.
Clinical Bottom Line
The evidence for Xango juice consists of two small pilot studies with modest effects on inflammatory biomarkers but no demonstrated impact on clinical outcomes (morbidity, mortality, or quality of life). The cost and effort of consuming 18 oz daily of a specialty beverage is not justified when:
- Established dietary patterns (Mediterranean diet) have stronger evidence for reducing inflammation
- No guidelines recommend mangosteen products for any inflammatory condition
- The clinical significance of small CRP reductions in these studies is unclear
- Standard anti-inflammatory therapies (NSAIDs, DMARDs, biologics) have proven efficacy for inflammatory diseases
Practical Recommendation
Direct patients with inflammatory conditions toward evidence-based Mediterranean dietary patterns 5 emphasizing:
- Daily consumption of fruits, vegetables, whole grains, legumes, nuts
- Olive oil as primary fat source
- Fish 2-3 times weekly for omega-3 fatty acids
- Limited red meat and processed foods
- Adequate fiber intake (25-35g daily)
If patients specifically ask about mangosteen juice, acknowledge the preliminary research but explain that the evidence is insufficient to recommend it over proven dietary approaches, and it should not replace standard medical therapy for inflammatory diseases.